Wells Fargo & Company Cure Vac N.V. Transaction History

Wells Fargo & Company

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$2.74 - $3.79 $4,614 - $6,382	-1,684 Closed	0 $0
Q2 2024 Aug 13, 2024	SELL	$2.31 - $4.99 $3,850 - $8,318	-1,667 Reduced 49.75%	1,684 $5,000
Q1 2024 May 10, 2024	BUY	$2.94 - $4.34 $8,940 - $13,197	3,041 Added 980.97%	3,351 $10,000
Q3 2023 Nov 13, 2023	SELL	$6.5 - $10.77 $585 - $969	-90 Reduced 22.5%	310 $2,000
Q2 2023 Aug 15, 2023	SELL	$6.69 - $12.25 $2,676 - $4,900	-400 Reduced 50.0%	400 $4,000
Q1 2023 May 12, 2023	SELL	$6.38 - $12.5 $644 - $1,262	-101 Reduced 11.21%	800 $5,000
Q4 2022 Feb 13, 2023	BUY	$5.75 - $8.5 $575 - $850	100 Added 12.48%	901 $5,000
Q3 2022 Nov 14, 2022	SELL	$7.48 - $15.24 $3,351 - $6,827	-448 Reduced 35.87%	801 $7,000
Q2 2022 Aug 12, 2022	BUY	$13.18 - $19.41 $10,952 - $16,129	831 Added 198.8%	1,249 $17,000
Q1 2022 May 16, 2022	SELL	$14.73 - $35.25 $3,815 - $9,129	-259 Reduced 38.26%	418 $8,000
Q4 2021 Feb 14, 2022	BUY	$33.72 - $48.22 $9,273 - $13,260	275 Added 68.41%	677 $24,000
Q3 2021 Nov 15, 2021	SELL	$49.26 - $74.5 $14,778 - $22,350	-300 Reduced 42.74%	402 $22,000
Q2 2021 Aug 16, 2021	SELL	$56.91 - $127.53 $42,454 - $95,137	-746 Reduced 51.52%	702 $51,000
Q1 2021 May 13, 2021	BUY	$79.79 - $126.29 $92,396 - $146,243	1,158 Added 399.31%	1,448 $132,000
Q4 2020 Feb 09, 2021	BUY	$46.76 - $136.27 $1,870 - $5,450	40 Added 16.0%	290 $24,000
Q3 2020 Nov 05, 2020	BUY	$43.8 - $77.2 $10,950 - $19,300	250 New	250 $12,000

12.3M

164K

117K

Ticker CVAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,467,008
Market Cap $467M
Description
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.